{"id":868027,"date":[{"year":1992,"month":5,"day":8}],"page":"3","source":"本报","region":"","masthead":"科教文卫新闻·体育新闻","special_issue":"","column":"","genre":"","count":"186","ytitle":"","mtitle":"6小时内可使心肌梗塞患者复活","ftitle":"","authors":[],"text":[{"type":"paragraph","text":"本报讯　6小时内可使心肌梗塞者复活。昨天，德国勃林格·英格翰公司与国家医药管理局上海医药工业研究院共同举办了新型溶栓剂R-TPA学术上海讨论会。R-TPA是德国勃林格·英格翰公司在国际上首先用基因工程方法研究生产的新型血栓选择性溶栓剂，急性心肌梗塞病人症状发作后6小时内服药，血管再通率可达84%，明显降低心肌梗塞的病死率。"}]}